PS3-6: Blood Safety Continuous Active-Surveillance Network Feasibility Evaluation (Blood-SCAN)

BACKGROUND/AIMS: In 2011, the US Food and Drug Administration (FDA) created the Blood Safety Continuous Active-Surveillance Network (Blood-SCAN), the first nationwide active surveillance system for monitoring the safety of FDA-regulated blood components and blood-derived products. Blood-SCAN employs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Baker, Meghan, Nguyen, Michael, Mullersman, Jerald, Lauer, Jillian, Zinderman, Craig, Riedlinger, Karen, Nakasato, Cynthia, Chrischilles, Elizabeth, Garcia, Crystal, Balsbaugh, Carolyn, Vajani, Madhavi
Format: Artigo
Idioma:Inglês
Publicat: Marshfield Clinic 2013
Matèries:
Selected Abstracts-HMORN 2013: Pharmacoepidemiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3788538/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2013.1176.ps3-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars